Let's meet for coffee
Schedule a meeting or connect with me on LinkedIn to discuss your upcoming study and how PSI can help.
Rhonda Critchlow
Senior Director, Operations
Mobile: (574) 309-1426
rhonda.critchlow@psi-cro.com
Global CRO focused on pivotal Phase 2 and 3 trials
As a leading oncology CRO, we have diverse experience in various classes of small molecules and biologics across a broad spectrum of cancers, including lung, breast, GI, GU, skin, leukemias, lymphomas, multiple myeloma, and MPNs. We work collaboratively with our Valued Sites to develop streamlined processes which decrease start-up timelines and promote efficiencies for our sponsors, sites, and PSI.
Read our latest white paper
Learn more with the resources below
PSI OVERVIEW
Our mission is to be the best CRO in the world as measured by our employees, clients, investigators, and vendors.
CASE STUDY
Find out how PSI helped one of our partners cut their startup timelines in half on a global HemOnc study.
ONCOLOGY
Running oncology studies globally. We plan and execute seamless clinical trials with novel study designs.
HEMATOLOGY
PSI is one, if not the only, CRO that has been engaged extensively in gene therapy trials by half a dozen biotech sponsors.
RARE DISEASE
The challenges of rare disease research, a global approach. Predictability in rare disease clinical trials.
RADIOPHARM
For radiopharmaceutical clinical trials, cooperation and coordination on a global scale is a must.